This blood test panel is used to confirm whether or not an individual has had hepatitis A or has been immunized by detecting the presence of HAV antibodies.
The FibroTestO (proprietary formula; Biopredictive, Paris, France, licensed under the name of FibrosureO in the USA (LabCorp, Burlington, NC, USA)) was the first algorithm combining several parameters [21]. Several... European Association for the Study of the Liver,Asociación Latinoamericana...